US Stock MarketDetailed Quotes

ZNTL Zentalis Pharmaceuticals

Watchlist
  • 3.610
  • -0.020-0.55%
Close Nov 29 13:00 ET
  • 3.660
  • +0.050+1.39%
Post 17:01 ET
257.27MMarket Cap-1444P/E (TTM)

Zentalis Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-13.91%-44.05M
55.67%-35.14M
-5.46%-51.97M
-26.91%-207.82M
-8.76%-40.6M
-16.46%-38.67M
-84.24%-79.28M
1.82%-49.28M
-6.27%-163.75M
-0.83%-37.33M
Net income from continuing operations
27.70%-40.16M
21.58%-88.28M
115.87%10.04M
-23.28%-292.31M
-10.83%-60.94M
-1.91%-55.54M
-64.59%-112.56M
-6.79%-63.26M
-42.76%-237.11M
-9.76%-54.98M
Operating gains losses
--0
-99.61%53K
-106.28%-145K
0.50%16.42M
-94.10%410K
--0
153.94%13.7M
31.92%2.31M
133.98%16.34M
279.36%6.95M
Depreciation and amortization
-7.76%321K
-4.94%327K
-10.00%324K
-2.59%1.39M
-6.13%337K
-7.20%348K
-1.15%344K
4.65%360K
162.13%1.43M
71.77%359K
Deferred tax
--0
--0
--0
-10.92%-853K
--0
--0
-1,121.62%-756K
-31.08%-97K
69.36%-769K
-1,502.08%-769K
Other non cash items
--0
--0
---25.56M
--15.05M
--0
--0
----
----
----
----
Change In working capital
-251.87%-7.26M
373.02%14.1M
-305.70%-16.31M
-55.75%5.86M
157.80%10.27M
-50.37%4.78M
-277.27%-5.16M
-22.79%-4.02M
-20.19%13.25M
64.93%3.98M
-Change in prepaid assets
526.00%5.44M
259.80%1.61M
63.80%-1.06M
14.03%-5.68M
74.64%-479K
-165.59%-1.28M
59.94%-1.01M
29.78%-2.92M
-610.43%-6.61M
-369.90%-1.89M
-Change in payables and accrued expense
-289.79%-12.01M
368.48%11.8M
-980.72%-15.25M
-29.68%10.92M
105.88%10.4M
-1.94%6.33M
-197.10%-4.39M
-182.20%-1.41M
11.19%15.53M
205.32%5.05M
-Change in other working capital
-154.61%-690K
----
----
-85.61%623K
-57.42%350K
-122.03%-271K
-73.80%235K
-77.62%309K
221.46%4.33M
-44.16%822K
Cash from discontinued investing activities
Operating cash flow
-13.91%-44.05M
55.67%-35.14M
-5.46%-51.97M
-26.91%-207.82M
-8.76%-40.6M
-16.46%-38.67M
-84.24%-79.28M
1.82%-49.28M
-6.27%-163.75M
-0.83%-37.33M
Investing cash flow
Cash flow from continuing investing activities
141.08%48.24M
-52.71%34.49M
46.11%61.55M
61.06%-44.46M
-253.62%-42.06M
-686.73%-117.45M
151.32%72.93M
112.78%42.12M
-530.31%-114.18M
-127.49%-11.89M
Net PPE purchase and sale
--0
63.64%-116K
---40K
77.12%-583K
-8.13%-173K
94.52%-91K
-14.75%-319K
--0
58.28%-2.55M
92.70%-160K
Net business purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Net investment purchase and sale
141.11%48.24M
-52.76%34.61M
46.21%61.59M
60.70%-43.88M
-256.97%-41.89M
-641.38%-117.36M
151.65%73.25M
108.05%42.12M
-4,928.37%-111.63M
-125.81%-11.73M
Cash from discontinued investing activities
Investing cash flow
141.08%48.24M
-52.71%34.49M
46.11%61.55M
61.06%-44.46M
-253.62%-42.06M
-686.73%-117.45M
151.32%72.93M
112.78%42.12M
-530.31%-114.18M
-127.49%-11.89M
Financing cash flow
Cash flow from continuing financing activities
-70.23%92K
-100.00%9K
-98.12%7K
-9.09%237.3M
0
-47.54%309K
12.97%236.62M
-70.35%373K
46.23%261.04M
305.49%49.74M
Net common stock issuance
-70.23%92K
-100.00%9K
-33.51%248K
-9.09%237.3M
--0
-47.54%309K
12.97%236.62M
-70.35%373K
45.29%261.04M
270.84%49.74M
Net other financing activities
--0
--0
---241K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-70.23%92K
-100.00%9K
-98.12%7K
-9.09%237.3M
--0
-47.54%309K
12.97%236.62M
-70.35%373K
46.23%261.04M
305.49%49.74M
Net cash flow
Beginning cash position
-85.27%39.66M
3.57%40.3M
-32.78%30.72M
-26.98%45.7M
150.96%113.38M
365.96%269.19M
16.34%38.91M
-26.98%45.7M
11.22%62.58M
2.51%45.18M
Current changes in cash
102.75%4.29M
-100.28%-640K
241.08%9.58M
11.32%-14.98M
-16,057.34%-82.66M
-1,137.35%-155.81M
846.56%230.28M
76.70%-6.79M
-367.51%-16.89M
-97.20%518K
End cash Position
-61.24%43.95M
-85.27%39.66M
3.57%40.3M
-32.78%30.72M
-32.78%30.72M
150.96%113.38M
365.96%269.19M
16.34%38.91M
-26.98%45.7M
-26.98%45.7M
Free cash flow
-13.65%-44.05M
55.62%-35.32M
-5.54%-52.01M
-25.32%-208.41M
-8.76%-40.77M
-11.18%-38.76M
-83.80%-79.59M
2.69%-49.28M
-3.81%-166.3M
4.39%-37.49M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -13.91%-44.05M55.67%-35.14M-5.46%-51.97M-26.91%-207.82M-8.76%-40.6M-16.46%-38.67M-84.24%-79.28M1.82%-49.28M-6.27%-163.75M-0.83%-37.33M
Net income from continuing operations 27.70%-40.16M21.58%-88.28M115.87%10.04M-23.28%-292.31M-10.83%-60.94M-1.91%-55.54M-64.59%-112.56M-6.79%-63.26M-42.76%-237.11M-9.76%-54.98M
Operating gains losses --0-99.61%53K-106.28%-145K0.50%16.42M-94.10%410K--0153.94%13.7M31.92%2.31M133.98%16.34M279.36%6.95M
Depreciation and amortization -7.76%321K-4.94%327K-10.00%324K-2.59%1.39M-6.13%337K-7.20%348K-1.15%344K4.65%360K162.13%1.43M71.77%359K
Deferred tax --0--0--0-10.92%-853K--0--0-1,121.62%-756K-31.08%-97K69.36%-769K-1,502.08%-769K
Other non cash items --0--0---25.56M--15.05M--0--0----------------
Change In working capital -251.87%-7.26M373.02%14.1M-305.70%-16.31M-55.75%5.86M157.80%10.27M-50.37%4.78M-277.27%-5.16M-22.79%-4.02M-20.19%13.25M64.93%3.98M
-Change in prepaid assets 526.00%5.44M259.80%1.61M63.80%-1.06M14.03%-5.68M74.64%-479K-165.59%-1.28M59.94%-1.01M29.78%-2.92M-610.43%-6.61M-369.90%-1.89M
-Change in payables and accrued expense -289.79%-12.01M368.48%11.8M-980.72%-15.25M-29.68%10.92M105.88%10.4M-1.94%6.33M-197.10%-4.39M-182.20%-1.41M11.19%15.53M205.32%5.05M
-Change in other working capital -154.61%-690K---------85.61%623K-57.42%350K-122.03%-271K-73.80%235K-77.62%309K221.46%4.33M-44.16%822K
Cash from discontinued investing activities
Operating cash flow -13.91%-44.05M55.67%-35.14M-5.46%-51.97M-26.91%-207.82M-8.76%-40.6M-16.46%-38.67M-84.24%-79.28M1.82%-49.28M-6.27%-163.75M-0.83%-37.33M
Investing cash flow
Cash flow from continuing investing activities 141.08%48.24M-52.71%34.49M46.11%61.55M61.06%-44.46M-253.62%-42.06M-686.73%-117.45M151.32%72.93M112.78%42.12M-530.31%-114.18M-127.49%-11.89M
Net PPE purchase and sale --063.64%-116K---40K77.12%-583K-8.13%-173K94.52%-91K-14.75%-319K--058.28%-2.55M92.70%-160K
Net business purchase and sale --------------0------------------0----
Net investment purchase and sale 141.11%48.24M-52.76%34.61M46.21%61.59M60.70%-43.88M-256.97%-41.89M-641.38%-117.36M151.65%73.25M108.05%42.12M-4,928.37%-111.63M-125.81%-11.73M
Cash from discontinued investing activities
Investing cash flow 141.08%48.24M-52.71%34.49M46.11%61.55M61.06%-44.46M-253.62%-42.06M-686.73%-117.45M151.32%72.93M112.78%42.12M-530.31%-114.18M-127.49%-11.89M
Financing cash flow
Cash flow from continuing financing activities -70.23%92K-100.00%9K-98.12%7K-9.09%237.3M0-47.54%309K12.97%236.62M-70.35%373K46.23%261.04M305.49%49.74M
Net common stock issuance -70.23%92K-100.00%9K-33.51%248K-9.09%237.3M--0-47.54%309K12.97%236.62M-70.35%373K45.29%261.04M270.84%49.74M
Net other financing activities --0--0---241K----------------------------
Cash from discontinued financing activities
Financing cash flow -70.23%92K-100.00%9K-98.12%7K-9.09%237.3M--0-47.54%309K12.97%236.62M-70.35%373K46.23%261.04M305.49%49.74M
Net cash flow
Beginning cash position -85.27%39.66M3.57%40.3M-32.78%30.72M-26.98%45.7M150.96%113.38M365.96%269.19M16.34%38.91M-26.98%45.7M11.22%62.58M2.51%45.18M
Current changes in cash 102.75%4.29M-100.28%-640K241.08%9.58M11.32%-14.98M-16,057.34%-82.66M-1,137.35%-155.81M846.56%230.28M76.70%-6.79M-367.51%-16.89M-97.20%518K
End cash Position -61.24%43.95M-85.27%39.66M3.57%40.3M-32.78%30.72M-32.78%30.72M150.96%113.38M365.96%269.19M16.34%38.91M-26.98%45.7M-26.98%45.7M
Free cash flow -13.65%-44.05M55.62%-35.32M-5.54%-52.01M-25.32%-208.41M-8.76%-40.77M-11.18%-38.76M-83.80%-79.59M2.69%-49.28M-3.81%-166.3M4.39%-37.49M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data